Aptus Pharma Ltd to expand into life saving injectables and ICU care products

Aptus Pharma Limited ("the Company"), further to its recent foray into the OTC and Uro Care segment, has initiated expansion into the Life-Saving Injectables and ICU Care product category.

The proposed portfolio will comprise products intended for the management of severe infections, sepsis, and other critical care conditions, primarily administered in hospital and intensive care settings. This strategic expansion aligns with the Company's objective of strengthening its presence across prescription, institutional, and retail healthcare segments.

The above expansion forms part of the Company's growth strategy and is expected to enhance its product portfolio in high-acuity therapeutic segments.

Shares of Aptus Pharma Limited was last trading in BSE at Rs. 271.95 as compared to the previous close of Rs. 266.65. The total number of shares traded during the day was 4000 in over 2 trades.

The stock hit an intraday high of Rs. 271.95 and intraday low of 271.95. The net turnover during the day was Rs. 1087800.00.

Source : Equity Bulls

Keywords

AptusPharma INE15XJ01010 Pharmaceuticals Expansion LifeSavingInjectables ICUCareProducts